Starving out brain tumors: a reprogrammed lysine catabolism serves as a novel target for glioblastoma treatment

Signal Transduct Target Ther. 2023 Oct 9;8(1):401. doi: 10.1038/s41392-023-01616-z.
No abstract available

MeSH terms

  • Brain Neoplasms* / drug therapy
  • Brain Neoplasms* / genetics
  • Brain Neoplasms* / metabolism
  • Glioblastoma* / drug therapy
  • Glioblastoma* / genetics
  • Glioblastoma* / metabolism
  • Humans
  • Lysine / metabolism

Substances

  • Lysine